ArticleActa pharmaceutica Sinica. B2025

GPC3-mediated lysosome-targeting chimeras (GLTACs) for targeted degradation of membrane proteins.

Yuxin Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.